GemCis Plus PD-1/PD-L1 Inhibitor in Advanced Biliary Tract Cancer: Efficacy and Immune Microenvironment （BTC-IM-1）
Clinical trial NCT06988592 · RECRUITING
Trial details
- NCT number
- NCT06988592
- Sponsor
- Fudan University
- Status
- RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2025-05-23
- Primary completion
- 2027-05-18
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.